Skip to main content

Pulmonary Clinical Applications for Mesenchymal Stem Cells

  • 2209 Accesses

Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)

Abstract

Lung disease remains a significant health and economic burden to societies throughout the world and is projected to increase in prevalence. Recent medical advances have enhanced clinical care but further research is needed in the areas of inhibition of lung fibrosis, altering airway inflammation and manipulating the pulmonary vascular endothelium. Stem cells have the potential to address these deficiencies by their remarkable ability to differentiate into various tissue lines and regulate internal repair systems. These unique regenerative abilities provide a novel approach to management for those suffering from pulmonary disease.

Keywords

  • Mesenchymal stem cells
  • Lung disease
  • Immunosuppression

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-62703-200-1_5
  • Chapter length: 13 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   149.00
Price excludes VAT (USA)
  • ISBN: 978-1-62703-200-1
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   199.99
Price excludes VAT (USA)
Hardcover Book
USD   279.99
Price excludes VAT (USA)
Fig. 5.1

References

  1. COPD (2003) COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 8(2):192–198

    CrossRef  Google Scholar 

  2. Stang P, Lydick E, Silberman C, Kempel A, Keating ET (2000) The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 117(5 Suppl 2):354S–359S

    PubMed  CrossRef  CAS  Google Scholar 

  3. Halpin DM, Miravitlles M (2006) Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc 3(7):619–623

    PubMed  CrossRef  Google Scholar 

  4. Ohnishi S, Nagaya N (2008) Tissue regeneration as next-generation therapy for COPD – potential applications. Int J Chron Obstruct Pulmon Dis 3(4):509–514

    PubMed  Google Scholar 

  5. Braman SS (2006) The global burden of asthma. Chest 130(1 Suppl):4S–12S

    PubMed  CrossRef  Google Scholar 

  6. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174(7):810–816

    PubMed  CrossRef  Google Scholar 

  7. Liu KD, Matthay MA (2008) Advances in critical care for the nephrologist: acute lung injury/ARDS. Clin J Am Soc Nephrol 3(2):578–586

    PubMed  CrossRef  CAS  Google Scholar 

  8. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4):954–963

    PubMed  CrossRef  CAS  Google Scholar 

  9. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S (2007) An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30(1):104–109

    PubMed  CrossRef  CAS  Google Scholar 

  10. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC (2008) Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 32(2):321–328

    PubMed  CrossRef  CAS  Google Scholar 

  11. Spencer H, Jaffe A (2004) The potential for stem cell therapy in cystic fibrosis. J R Soc Med 97(Suppl 44):52–56

    PubMed  Google Scholar 

  12. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP (2007) Stem cell transplantation: the lung barrier. Transplant Proc 39(2):573–576

    PubMed  CrossRef  CAS  Google Scholar 

  13. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175(1):303–313

    Google Scholar 

  14. Yan X, Liu Y, Han Q, Jia M, Liao L, Qi M, Zhao RC (2007) Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp Hematol 35(9):1466–1475

    PubMed  CrossRef  CAS  Google Scholar 

  15. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179(3):1855–1863

    PubMed  CAS  Google Scholar 

  16. Qin ZH, Qu JM, Xu JF, Zhang J, Summah H, Sai-Yin HX, Chen CM, Yu L (2011) Intrapleural delivery of mesenchymal stem cells: a novel potential treatment for pleural diseases. Acta Pharmacol Sin 32(5):581–590

    PubMed  CrossRef  CAS  Google Scholar 

  17. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31(10):890–896

    PubMed  CrossRef  Google Scholar 

  18. Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15(8–9):711–721

    PubMed  CrossRef  Google Scholar 

  19. Rasmusson I, Uhlin M, Le Blanc K, Levitsky V (2007) Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes. J Leukoc Biol 82(4):887–893

    PubMed  CrossRef  CAS  Google Scholar 

  20. Badillo AT, Beggs KJ, Javazon EH, Tebbets JC, Flake AW (2007) Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response. Biol Blood Marrow Transplant 13(4):412–422

    PubMed  CrossRef  CAS  Google Scholar 

  21. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108(6):2114–2120

    PubMed  CrossRef  CAS  Google Scholar 

  22. Poggi A, Prevosto C, Zancolli M, Canevali P, Musso A, Zocchi MR (2007) NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells. Ann N Y Acad Sci 1109:47–57

    PubMed  CrossRef  CAS  Google Scholar 

  23. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells (Dayton, Ohio) 24(1):74–85

    CrossRef  Google Scholar 

  24. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, Spees JL, Bertucci D, Peister A, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK (2005) Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci USA 102(1):186–191

    PubMed  CrossRef  CAS  Google Scholar 

  25. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, Weiss DJ (2008) Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Critic Care Med 177(7):701–711

    Google Scholar 

  26. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N, Salvayre AN, Bourin P, Parini A, Cussac D (20009) Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells (Dayton, Ohio)

    Google Scholar 

  27. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100(14):8407–8411

    PubMed  CrossRef  CAS  Google Scholar 

  28. Gotherstrom C (2007) Immunomodulation by multipotent mesenchymal stromal cells. Transplantation 84(1 Suppl):S35–S37

    PubMed  CrossRef  Google Scholar 

  29. Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN (2008) Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 181(6):4389–4396

    PubMed  CAS  Google Scholar 

  30. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838–3843

    PubMed  CrossRef  Google Scholar 

  31. Lee JW, Gupta N, Serikov V, Matthay MA (2009) Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 9(10):1259–1270

    PubMed  CrossRef  CAS  Google Scholar 

  32. Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW (2010) Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138(4):965–972

    PubMed  CrossRef  Google Scholar 

  33. Cui A, Dai HP, Dai JW, Pang BS, Niu SJ, Lu YP, Wang C (2007) Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi 30(9):677–682

    PubMed  Google Scholar 

  34. Firinci F, Karaman M, Baran Y, Bagriyanik A, Ayyildiz ZA, Kiray M, Kozanoglu I, Yilmaz O, Uzuner N, Karaman O (2011) Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma. Int Immunopharmacol 11(8):1120–1126

    Google Scholar 

  35. Grove DA, Xu J, Joodi R, Torres-Gonzales E, Neujahr D, Mora AL, Rojas M (2011) Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. J Heart Lung Transplant 30(3):341–350

    PubMed  CrossRef  Google Scholar 

  36. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, Kourembanas S (2011) Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells (Dayton, Ohio) 29(1):99–107

    CrossRef  CAS  Google Scholar 

  37. Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A (2009) Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 297(5):H1606–H1616

    PubMed  CrossRef  CAS  Google Scholar 

  38. Allison M (2009) Genzyme backs Osiris, despite prochymal flop. Nat Biotechnol 27(11):966–967

    PubMed  CrossRef  CAS  Google Scholar 

  39. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S (2002) Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21(3):297–310

    PubMed  CrossRef  Google Scholar 

  40. Lama VN, Smith L, Badri L, Flint A, Andrei AC, Murray S, Wang Z, Liao H, Toews GB, Krebsbach PH, Peters-Golden M, Pinsky DJ, Martinez FJ, Thannickal VJ (2007) Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest 117(4):989–996

    Google Scholar 

  41. Badri L, Walker NM, Ohtsuka T, Wang Z, Delmar M, Flint A, Peters-Golden M, Toews GB, Pinsky DJ, Krebsbach PH, Lama VN (2011) Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol

    Google Scholar 

  42. McQualter JL, Yuen K, Williams B, Bertoncello I (2010) Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 107(4):1414–1419

    PubMed  CrossRef  CAS  Google Scholar 

  43. Walker N, Badri L, Wettlaufer S, Flint A, Sajjan U, Krebsbach PH, Keshamouni VG, Peters-Golden M, Lama VN (2011) Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. Am J Pathol 178(6):2461–2469

    PubMed  CrossRef  CAS  Google Scholar 

  44. Couzin J, Kaiser J (2005) Gene therapy: as Gelsinger case ends, gene therapy suffers another blow. Science (New York, NY) 307(5712):1028

    CrossRef  CAS  Google Scholar 

  45. Zhao F, Zhang YF, Liu YG, Zhou JJ, Li ZK, Wu CG, Qi HW (2008) Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 40(5):1700–1705

    PubMed  CrossRef  CAS  Google Scholar 

  46. Bitencourt CS, Pereira PA, Ramos SG, Sampaio SV, Arantes EC, Aronoff DM, Faccioli LH (2011) Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis. Fibrogenesis Tissue Repair 4(1):3

    PubMed  CrossRef  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Chambers .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chambers, D., Hopkins, P. (2013). Pulmonary Clinical Applications for Mesenchymal Stem Cells. In: Chase, L., Vemuri, M. (eds) Mesenchymal Stem Cell Therapy. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-200-1_5

Download citation